Thelansis

  Ewing sarcoma (ES), also called peripheral primitive neuroectodermal tumor is a type of tumor that forms from a certain kind of cell in bone or soft tissue. In Ewing sarcoma, the chromosomal areas involved are the long arms (q) of chromosomes 11 and 22 (11q24-22q12). These pieces break off and trade places. In most cases, this results in the abnormal fusion of two genes, usually the EWS and FLI genes. Approximately 200-250 children and adolescents in the United States are diagnosed with a tumor in the Ewing family of tumors each year. Two-thirds will be long-term survivors (more than five years). The annual incidence of Ewing sarcoma is 2.93 children per 10,00,000. Thelansis’s “Ewing Sarcoma (ES) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share,...